⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adult anaplastic ependymoma

Every month we try and update this database with for adult anaplastic ependymoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsNCT00499798
Brain and Centr...
Chemotherapeuti...
Infertility
18 Years - 60 YearsWake Forest University Health Sciences
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid TumorsNCT00008086
Brain and Centr...
Unspecified Adu...
calcitriol
carboplatin
18 Years - University of Pittsburgh
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsNCT00002647
Brain and Centr...
Metastatic Canc...
verteporfin
conventional su...
3 Years - 70 YearsNational Cancer Institute (NCI)
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaNCT00008008
Brain and Centr...
filgrastim
sargramostim
cyclophosphamid...
thiotepa
autologous bone...
bone marrow abl...
peripheral bloo...
- National Cancer Institute (NCI)
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain CancerNCT00025558
Brain and Centr...
filgrastim
carboplatin
temozolomide
thiotepa
autologous bone...
peripheral bloo...
1 Year - 49 YearsNYU Langone Health
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsNCT00005083
Brain and Centr...
conventional su...
magnetic resona...
magnetic resona...
18 Years - 55 YearsJonsson Comprehensive Cancer Center
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaNCT00401024
Brain and Centr...
imatinib mesyla...
pharmacological...
conventional su...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorNCT00069940
Brain and Centr...
Gastrointestina...
Sarcoma
sargramostim
telomerase: 540...
2 Years - Dana-Farber Cancer Institute
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or EpendymomaNCT00006258
Brain and Centr...
filgrastim
cisplatin
cyclophosphamid...
etoposide
methotrexate
vincristine sul...
adjuvant therap...
radiation thera...
10 Years - 65 YearsNational Cancer Institute (NCI)
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic GliomaNCT00756106
Brain and Centr...
temozolomide
Imaging biomark...
Photon Radiatio...
18 Years - Massachusetts General Hospital
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain TumorNCT00070161
Brain and Centr...
Radiation Toxic...
EGb761
donepezil hydro...
cognitive asses...
18 Years - 120 YearsWake Forest University Health Sciences
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaNCT00005082
Brain and Centr...
biopsy
magnetic resona...
18 Years - Jonsson Comprehensive Cancer Center
Carmustine in Treating Patients With Recurrent Malignant GliomaNCT00004028
Brain and Centr...
carmustine
conventional su...
18 Years - National Cancer Institute (NCI)
Monoclonal Antibody Therapy in Treating Patients With Recurrent GliomasNCT00002753
Brain and Centr...
iodine I 131 mo...
3 Years - Duke University
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent GliomasNCT02175745
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Diffuse A...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Oligodend...
Adult Pilocytic...
Adult Pineal Gl...
Adult Subependy...
Childhood High-...
Childhood High-...
Childhood Low-g...
Childhood Low-g...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
18F-fluoro-dihy...
Positron emissi...
Computed tomogr...
Magnetic resona...
16 Years - Stanford University
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord TumorsNCT00541138
Brain and Centr...
Metastatic Canc...
Unspecified Adu...
carboplatin
tamoxifen citra...
topotecan hydro...
pharmacological...
18 Years - City of Hope Medical Center
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsNCT00002608
Adrenocortical ...
Brain and Centr...
Head and Neck C...
Liver Cancer
Malignant Mesot...
Pheochromocytom...
Sarcoma
cisplatin
doxorubicin hyd...
tamoxifen citra...
conventional su...
radiation thera...
- 65 YearsNational Cancer Institute (NCI)
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain CancerNCT00025558
Brain and Centr...
filgrastim
carboplatin
temozolomide
thiotepa
autologous bone...
peripheral bloo...
1 Year - 49 YearsNYU Langone Health
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesNCT02967380
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade II ...
Adult Medullobl...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineal Gl...
Adult Pineoblas...
Adult Primary M...
Adult Supratent...
Malignant Adult...
Metastatic Mali...
Multiple Sclero...
Recurrent Adult...
Dynamic Contras...
Gadobenate Dime...
Gadobutrol
Gadopentetate D...
18 Years - University of Southern California
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial GliomasNCT00083096
Brain and Centr...
lonafarnib
temozolomide
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or EpendymomaNCT00006258
Brain and Centr...
filgrastim
cisplatin
cyclophosphamid...
etoposide
methotrexate
vincristine sul...
adjuvant therap...
radiation thera...
10 Years - 65 YearsNational Cancer Institute (NCI)
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2NCT01082926
Anaplastic Astr...
Anaplastic Epen...
Anaplastic Meni...
Anaplastic Olig...
Brain Stem Glio...
Ependymoblastom...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Grade III Menin...
Meningeal Heman...
Mixed Glioma
Pineal Gland As...
Brain Tumor
therapeutic all...
aldesleukin
laboratory biom...
positron emissi...
18 Years - 70 YearsCity of Hope Medical Center
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic GliomaNCT00058123
Brain and Centr...
poly ICLC
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain TumorsNCT00003478
Brain and Centr...
conventional su...
iodine I 131 mo...
radiation thera...
18 Years - Duke University
Etoposide Plus Cisplatin in Treating Patients With Recurrent EpendymomasNCT00002876
Brain and Centr...
cisplatin
etoposide
18 Years - Mayo Clinic
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaNCT01095094
Brain Tumor
Anaplastic Astr...
Anaplastic Epen...
Anaplastic Olig...
Brain Stem Glio...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Mixed Glioma
ritonavir
lopinavir
18 Years - Case Comprehensive Cancer Center
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsNCT00110032
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Grade III...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Supratent...
Meningeal Melan...
EF5
conventional su...
positron emissi...
fluorine F 18 E...
pharmacological...
18 Years - National Cancer Institute (NCI)
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaNCT01119599
Acoustic Schwan...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Medullobl...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Papillary...
Adult Pilocytic...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Primary M...
Adult Subependy...
Adult Subependy...
Adult Supratent...
Malignant Adult...
3-Dimensional C...
Gamma-Secretase...
Intensity-Modul...
Laboratory Biom...
Pharmacological...
Temozolomide
Therapeutic Con...
19 Years - National Cancer Institute (NCI)
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesNCT01234740
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Recurrent Adult...
Tumors Metastat...
Adult Anaplasti...
bafetinib
microdialysis
pharmacological...
liquid chromato...
mass spectromet...
laboratory biom...
protein express...
western blottin...
immunohistochem...
therapeutic con...
18 Years - City of Hope Medical Center
Study of Tissue Samples From Patients With Glioma or Other Brain TumorsNCT00967200
Central Nervous...
laboratory biom...
pharmacogenomic...
18 Years - 120 YearsUniversity Hospital, Montpellier
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaNCT00005637
Brain and Centr...
carmustine
temozolomide
18 Years - National Cancer Institute (NCI)
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesNCT01234740
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Recurrent Adult...
Tumors Metastat...
Adult Anaplasti...
bafetinib
microdialysis
pharmacological...
liquid chromato...
mass spectromet...
laboratory biom...
protein express...
western blottin...
immunohistochem...
therapeutic con...
18 Years - City of Hope Medical Center
Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant GliomaNCT00430079
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Diffuse A...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Pineal Gl...
Adult Subependy...
etanidazole
conventional su...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
3T MRI Biomarkers of Glioma Treatment ResponseNCT01996527
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
3-Tesla magneti...
CEST-MRI
DW-MRI
DCE-MRI
DSC-MRI
IV administrati...
18 Years - Vanderbilt-Ingram Cancer Center
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain NeoplasmNCT00009854
Brain and Centr...
Metastatic Canc...
carmustine in e...
conventional su...
18 Years - 75 YearsNational Cancer Institute (NCI)
CC-5013 in Treating Patients With Recurrent GliomaNCT00036894
Brain and Centr...
lenalidomide
18 Years - National Cancer Institute (NCI)
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid TumorsNCT00008086
Brain and Centr...
Unspecified Adu...
calcitriol
carboplatin
18 Years - University of Pittsburgh
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant GliomaNCT00498927
Brain and Centr...
temozolomide
protein express...
reverse transcr...
diagnostic labo...
immunoenzyme te...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Study of Blood and Cheek Cell Samples From Patients With GliomaNCT01009307
Brain and Centr...
polymorphism an...
laboratory biom...
medical chart r...
18 Years - 120 YearsUniversity of California, San Francisco
Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain CancerNCT00003309
Brain and Centr...
filgrastim
cisplatin
cyclophosphamid...
etoposide
vincristine sul...
adjuvant therap...
radiation thera...
18 Years - 120 YearsEastern Cooperative Oncology Group
Enzastaurin and Temozolomide in Treating Patients With Primary GliomasNCT00516607
Brain and Centr...
enzastaurin hyd...
temozolomide
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic GliomaNCT00756106
Brain and Centr...
temozolomide
Imaging biomark...
Photon Radiatio...
18 Years - Massachusetts General Hospital
Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family CaregiversNCT00376818
Brain and Centr...
Psychosocial Ef...
exercise interv...
educational int...
physiologic tes...
management of t...
mind-body inter...
Measurement of ...
18 Years - Case Comprehensive Cancer Center
Veliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaNCT01026493
Brain and Centr...
temozolomide 60...
temozolomide 75...
ABT-888 20 mg x...
ABT-888 40 mg x...
Temozolomide 15...
ABT-888 40 mg x...
18 Years - 120 YearsRadiation Therapy Oncology Group
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaNCT00387933
Brain and Centr...
hydroxyurea
imatinib mesyla...
vatalanib
18 Years - Duke University
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsNCT01131234
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Solid Neo...
Male Breast Car...
Recurrent Adult...
Recurrent Breas...
Recurrent Colon...
Recurrent Melan...
Recurrent Non-S...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Stage III Pancr...
Stage III Renal...
Stage IIIA Colo...
Stage IIIA Non-...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Skin...
Stage IIIB Brea...
Stage IIIB Colo...
Stage IIIB Non-...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Skin...
Stage IIIC Brea...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Skin...
Stage IV Breast...
Stage IV Non-Sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Skin M...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
Gamma-Secretase...
Cediranib Malea...
Pharmacological...
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersNCT00255671
Brain and Centr...
Metastatic Canc...
Radiation Toxic...
Questionnaire
18 Years - Case Comprehensive Cancer Center
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesNCT02967380
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade II ...
Adult Medullobl...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineal Gl...
Adult Pineoblas...
Adult Primary M...
Adult Supratent...
Malignant Adult...
Metastatic Mali...
Multiple Sclero...
Recurrent Adult...
Dynamic Contras...
Gadobenate Dime...
Gadobutrol
Gadopentetate D...
18 Years - University of Southern California
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord TumorsNCT00541138
Brain and Centr...
Metastatic Canc...
Unspecified Adu...
carboplatin
tamoxifen citra...
topotecan hydro...
pharmacological...
18 Years - City of Hope Medical Center
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant GliomaNCT00352521
Brain and Centr...
bevacizumab
irinotecan
dynamic contras...
18 Years - Duke University
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade GliomasNCT02186509
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Diffuse A...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Oligodend...
Adult Pilocytic...
Adult Pineal Gl...
Adult Subependy...
Recurrent Adult...
Hyperfractionat...
Stereotactic ra...
Alisertib
Quality-of-life...
18 Years - Thomas Jefferson University
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain TumorsNCT00629889
Brain and Centr...
Seizure
levetiracetam
pregabalin
18 Years - Centre Hospitalier Universitaire Vaudois
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain CancerNCT00014573
Brain and Centr...
aldesleukin
autologous tumo...
filgrastim
sargramostim
therapeutic aut...
carmustine
cisplatin
cyclophosphamid...
paclitaxel
autologous bone...
conventional su...
peripheral bloo...
- 65 YearsBarbara Ann Karmanos Cancer Institute
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant GliomaNCT00730613
Brain and Centr...
therapeutic aut...
gene expression...
laboratory biom...
18 Years - 70 YearsCity of Hope Medical Center
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With GliomasNCT00276770
Brain and Centr...
fluorine F 18 f...
positron emissi...
18 Years - 120 YearsUniversity of Washington
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionNCT00030498
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Diffuse A...
Adult Ependymob...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Primary H...
Adult Subependy...
Advanced Adult ...
Advanced Malign...
Male Breast Can...
Recurrent Adeno...
Recurrent Adult...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Bladd...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Malig...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage II Esopha...
Stage II Pancre...
Stage III Esoph...
Stage III Pancr...
Stage IIIB Non-...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Bladde...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Unspecified Adu...
Untreated Metas...
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyNCT00471653
Brain and Centr...
Thrombocytopeni...
temozolomide
comparative gen...
polymorphism an...
laboratory biom...
pharmacological...
radiation thera...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaNCT00003567
Brain and Centr...
Lymphoma
Unspecified Adu...
filgrastim
sargramostim
therapeutic aut...
O6-benzylguanin...
carmustine
temozolomide
in vitro-treate...
18 Years - 70 YearsCase Comprehensive Cancer Center
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain CancersNCT00002752
Brain and Centr...
Metastatic Canc...
iodine I 131 mo...
3 Years - Duke University
Yoga Therapy in Treating Patients With Malignant Brain TumorsNCT01234805
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Supratent...
Recurrent Adult...
yoga therapy
questionnaire a...
quality-of-life...
18 Years - Wake Forest University Health Sciences
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNCT00006368
Brain and Centr...
Breast Cancer
Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Lymphoma
Melanoma (Skin)
Neoplastic Synd...
yttrium Y 90-ed...
18 Years - Novartis
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaNCT00003567
Brain and Centr...
Lymphoma
Unspecified Adu...
filgrastim
sargramostim
therapeutic aut...
O6-benzylguanin...
carmustine
temozolomide
in vitro-treate...
18 Years - 70 YearsCase Comprehensive Cancer Center
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to TreatmentNCT00544284
Brain and Centr...
Lymphoma
Metastatic Canc...
Unspecified Adu...
bortezomib
temozolomide
pharmacological...
18 Years - City of Hope Medical Center
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsNCT02194452
Acoustic Schwan...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Papillary...
Adult Pilocytic...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Subependy...
Adult Supratent...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Supra...
Meningeal Melan...
Newly Diagnosed...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
gallium Ga 68-e...
positron emissi...
computed tomogr...
laboratory biom...
6 Months - 29 YearsUniversity of Iowa
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord TumorsNCT00541138
Brain and Centr...
Metastatic Canc...
Unspecified Adu...
carboplatin
tamoxifen citra...
topotecan hydro...
pharmacological...
18 Years - City of Hope Medical Center
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent GliomasNCT01478321
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Temozolomide
hypofractionate...
bevacizumab
questionnaire a...
18 Years - Northwestern University
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNCT00492089
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain TumorsNCT00629889
Brain and Centr...
Seizure
levetiracetam
pregabalin
18 Years - Centre Hospitalier Universitaire Vaudois
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorNCT00069940
Brain and Centr...
Gastrointestina...
Sarcoma
sargramostim
telomerase: 540...
2 Years - Dana-Farber Cancer Institute
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaNCT00387933
Brain and Centr...
hydroxyurea
imatinib mesyla...
vatalanib
18 Years - Duke University
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial GliomasNCT00083096
Brain and Centr...
lonafarnib
temozolomide
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain NeoplasmNCT00009854
Brain and Centr...
Metastatic Canc...
carmustine in e...
conventional su...
18 Years - 75 YearsNational Cancer Institute (NCI)
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With GliomasNCT00276770
Brain and Centr...
fluorine F 18 f...
positron emissi...
18 Years - 120 YearsUniversity of Washington
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaNCT00008008
Brain and Centr...
filgrastim
sargramostim
cyclophosphamid...
thiotepa
autologous bone...
bone marrow abl...
peripheral bloo...
- National Cancer Institute (NCI)
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNCT00492089
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Veliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaNCT01026493
Brain and Centr...
temozolomide 60...
temozolomide 75...
ABT-888 20 mg x...
ABT-888 40 mg x...
Temozolomide 15...
ABT-888 40 mg x...
18 Years - 120 YearsRadiation Therapy Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: